Buscar
Quanterix Corp
QTRXAñadir a la lista de seguimiento
4.330USD
-0.010-0.23%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
203.77MCap. mercado
PérdidaP/E TTM
Más Datos de Quanterix Corp Compañía
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
Información de Quanterix Corp
Símbolo de cotizaciónQTRX
Nombre de la empresaQuanterix Corp
Fecha de salida a bolsaDec 07, 2017
Director ejecutivoToloue (Masoud)
Número de empleados471
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 07
Dirección900 Middlesex Turnpike
CiudadBILLERICA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01821
Teléfono16173019400
Sitio Webhttps://www.quanterix.com/
Símbolo de cotizaciónQTRX
Fecha de salida a bolsaDec 07, 2017
Director ejecutivoToloue (Masoud)
Ejecutivos de Quanterix Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
154.13K
+8.83%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
12.35K
-155.84%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
11.39K
-139.92%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
6.97K
-335.42%
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Garret Hampton, Ph.D.
Dr. Garret Hampton, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alan Sachs, M.D., Ph.D.
Dr. Alan Sachs, M.D., Ph.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
154.13K
+8.83%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
12.35K
-155.84%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
11.39K
-139.92%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Quanterix Corp?
Los cinco principales accionistas de Quanterix Corp son: Dr. Masoud Toloue, Ph.D.
¿Cuántas instituciones poseen acciones de Quanterix Corp (QTRX)?
A fecha de 2026Q1, 371 instituciones poseen acciones de Quanterix Corp, con un valor de mercado combinado de aproximadamente 42.63M, lo que representa el 90.49% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -4982326.00.
¿Cuál es la mayor fuente de ganancias de Quanterix Corp?
El 2026Q1, el segmento empresarial Product revenue generó la ganancia más alta para Quanterix Corp, ascendiendo a 92.94M y representando el 67.03% de la ganancia total.